Galectin Therapeutics Inc (NASDAQ:GALT)

3.54
Delayed Data
As of Mar 27
 -0.01 / -0.28%
Today’s Change
3.00
Today|||52-Week Range
17.14
+2.02%
Year-to-Date
No recent news for Galectin Therapeutics Inc.

Today’s Trading

Previous close3.55
Today’s open3.56
Day’s range3.50 - 3.73
Volume63,423
Average volume (3 months)278,984
Market cap$83.4M
Dividend yield--
Data as of 4:00pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)+40.00%
Earnings growth (this year)+2.56%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.82

Competitors

 Today’s
change
Today’s
% change
TRILTrillium Therapeutic...+1.39+8.19%
CGIXCancer Genetics Inc-0.13-1.69%
GBIMGlobeImmune Inc+0.28+3.93%
GBSNUGreat Basin Scientif...+0.20+1.92%
Data as of 4:00pm ET, 03/27/2015

Financials

Next reporting dateMay 15, 2015
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$0.00
Annual profit (last year)-$16.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Director &
Chief Medical Officer
Peter G. Traber
Chief Operating Officer &
Secretary
Harold H. Shlevin
Corporate headquarters
Norcross, Georgia

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account